NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,571,000 | -17.2% | 3,300,000 | 0.0% | 0.17% | -32.2% |
| Q2 2020 | $5,520,000 | -27.3% | 3,300,000 | -44.1% | 0.24% | -3.5% |
| Q1 2020 | $7,590,000 | -78.5% | 5,900,000 | -74.3% | 0.25% | -57.3% |
| Q4 2019 | $35,258,000 | +43.2% | 22,950,000 | +27.9% | 0.60% | +65.3% |
| Q3 2019 | $24,622,000 | +10.0% | 17,950,000 | +5.6% | 0.36% | +41.2% |
| Q2 2019 | $22,389,000 | -17.3% | 17,000,000 | -15.0% | 0.26% | -25.0% |
| Q1 2019 | $27,077,000 | +654.4% | 20,000,000 | +566.7% | 0.34% | +593.9% |
| Q4 2018 | $3,589,000 | – | 3,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |